| Somatic mutation analysis of JAK2 gene in exons 12 and 14 |
12 working days |
| Somatic mutation analysis of JAK2 gene in exon 12 |
12 working days |
| Somatic mutation analysis of JAK2 gene in exon 14 |
1 working week |
| Somatic mutation analysis of CALR gene in exon 9 |
12 working days |
| Somatic mutation analysis of MPL gene in exon 10 |
12 working days |
| Qualitative detection of BCR-ABL P190 chromosomal translocation (t(9;22)) |
1 working week |
| Qualitative detection of BCR-ABL P210 chromosomal translocation (t(9;22)) |
1 working week |
| Quantitative detection of BCR-ABL P190 chromosomal translocation (t(9;22)) |
10 working days |
| Quantitative detection of BCR-ABL P210 chromosomal translocation (t(9;22)) |
10 working days |
| EGFR mutation testing |
15 working days |
| KRAS mutation testing |
15 working days |
| NRAS mutation testing |
15 working days |
| Somatic mutation analysis of BRAF gene (V600E hotspot) |
12 working days |
| Whole Exome Sequencing (WES) by NGS |
8–12 working weeks |
| Prostate Cancer Panel (NGS) |
8–12 working weeks |
| Prostate Cancer Somatic Testing |
8–12 working weeks |
| Ovarian + Breast Cancer Panel (NGS) |
8–12 working weeks |
| Colon Cancer Panel (NGS) |
8–12 working weeks |
| Hereditary Breast Cancer Panel (BRCA1 & BRCA2) by NGS |
8–12 working weeks |
| Somatic Breast Cancer Panel (BRCA1 & BRCA2) by NGS |
8–12 working weeks |
| Familial Cancer NGS Panel (160 genes) |
8–12 working weeks |
| Familial Cancer NGS Panel (244 genes) |
8–12 working weeks |
| Familial Cancer NGS Panel (360 genes) |
8–12 working weeks |
| Familial Cancer NGS Panel (810 genes) |
8–12 working weeks |
| Somatic Cancer Panel |
8–12 working weeks |
| Whole Exome Sequencing (WES) 100X (Rapid) |
6 working weeks |
| Whole Exome Sequencing (WES) 200 |
8–12 working weeks |
